References
- Beutler E. Glucose-6-phosphate dehydrogenase deficiency. In: Hematology, 2nd Edn, Williams W J, Beutler E, Erslev A J, Rundles R W (eds), New York, McGraw-Hill, 1977; 466.
- Beutler E. Glucose-6-phosphate dehydrogenase deficiency. In: The Metabolic Basis of Inherited Disease, 5th Edn, Stanbury J B, Wyngaarden J B, Fredrickson D S, Goldstein J L, Brown M S (eds), New York, McGraw-Hill, 1983; 1629.
- Baker M A, Bosia A, Pescarmona G, Turrini F, Arese P. Mechanism of the action of divicine in a cell-free system and in glucose-6-phosphate dehydrogenase-deficient red cells. Toxicol Pathol 1984; 12: 331.
- Beutler E, Dern R J, Alving A S. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med 1955; 45: 286.
- Carson P E, Flanagan C L, Ickes C E, Alving A S. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956; 124: 484.
- Beutler E, Robson M, Buttenwieser E. The mechanism of glutathione destruction and protection in drug-sensitive erythrocytes. In vitro studies. J Clin Invest 1957; 36: 617.
- Beutler E. The genetics of glucose-6-phosphate dehydrogenase deficiency. Seminars in Hematology 1990; 27: 137.
- Kirkrnan H N. Glucose-6-phosphate dehydrogenase. Adv Hum Genet 1971; 2: 1.
- Mareni C, Gaetani G F. NADP+ and NADPH in glucose-6-phosphate dehydrogenase deficient erythrocytes under oxidative stimulation. Biochim Biophys Acta 1976; 430: 395.
- Cohen G, Hochstein P. Glutathione peroxidase: The primary agent for the elimination of hydrogen peroxide in erythrocytes. Biochem 1963; 6: 1420.
- Scott M D, Zuo L, Lubin B H, Chiu D T-Y. NADPH, not glutathione, status modulates oxidant susceptibility of hemoglobin in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes. Blood 1991; 77: 2059.
- Scott M D, Lubin B H, Zuo L, Kuypers F A. Erythrocyte defense against H202: Pre-eminent importance of catalase. J Lab Clin Med 1991; 118: 7.
- Scott M D, Wagner T C, Chiu D T-Y. Catalase activity and oxidant susceptibility in glucose-6-phosphate dehydrogenase deficient erythrocytes. Biochim Biophys Acta 1993; 1181: 163.
- Gaetani G F, Canepa L, Galiano S, Ferraris A M, Kirkman H N. Catalase and glutathione peroxidase are equally active in the detoxification of hydrogen peroxide in human erythrocytes. Blood 1989; 73: 334.
- Eaton J W, Hallaway P E, Agar N S. Erythrocyte Glutathione: A Dispensable oxidant Defense? In: Brewer G J (ed.), The Red Cell. Seventh Ann Arbor Conference, Alan R. Liss, Inc. New York, 1989; 23.
- Scott M D, Wagner T C. Chloroquine inhibition of iron release from hemin, hemoglobin, and α-hemoglobin chains. Blood 1992; 80 (Suppl. 1): 290.
- Tarlov A R, Kellermeyer R W. Hemolytic effect of primaquine. IX. Decreased catalase activity in primaquine sensitive erythrocytes. J Lab Clin Med 1961; 58: 204.
- Eaton J W, Boraas M, Etkin N L. Catalase activity and red cell metabolism. In: Brewer G J (ed), Hemoglobin and Red Cell Structure and Function. New York, NY, Academic Press, 1972; 121.
- Kirkman H N, Gaetani G F. Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc Natl Acad Sci USA 1984; 81: 4343.
- Oshino N, Jamieson D, Sugano T, Chance B. Optical measurement of the catalase-hydrogen peroxide Intermediate (Compound I) in the liver of anaesthetized rats and its implication to hydrogen peroxide production in situ. Biochem J 1975; 146: 67.
- Oshino N, Jamieson D, Chance B. The properties of hydrogen peroxide production under hyperbaric and hypoxic conditions of perfused rat liver. Biochem J 1975; 146: 53.
- Jacob H S, Ingbar S H, Jandl J H. Oxidative hemolysis and erythrocyte metabolism in hereditary acatalasia. J Clin Invest 1965; 44: 1187.